vs
MID PENN BANCORP INC（MPB）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是MID PENN BANCORP INC的1.1倍（$69.8M vs $62.0M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 31.4%，领先352.7%），MID PENN BANCORP INC同比增速更快（30.8% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 21.1%）
该资料实际介绍的是1973年成立于新泽西州切里希尔的商业银行，该银行在2007年被多伦多道明银行收购，并入其旗下的TD Banknorth，之后TD Banknorth统一更名为TD银行。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
MPB vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.1倍
$62.0M
营收增速更快
MPB
高出9.6%
21.2%
净利率更高
RIGL
高出352.7%
31.4%
两年增速更快
RIGL
近两年复合增速
21.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.0M | $69.8M |
| 净利润 | $19.4M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 43.6% | 33.2% |
| 净利率 | 31.4% | 384.0% |
| 营收同比 | 30.8% | 21.2% |
| 净利润同比 | 47.0% | 1769.2% |
| 每股收益（稀释后） | $0.83 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MPBRIGL
| Q4 25 | $62.0M | $69.8M | ||
| Q3 25 | $61.8M | $69.5M | ||
| Q2 25 | $54.3M | $101.7M | ||
| Q1 25 | $47.7M | $53.3M | ||
| Q4 24 | $47.4M | $57.6M | ||
| Q3 24 | $45.3M | $55.3M | ||
| Q2 24 | $44.1M | $36.8M | ||
| Q1 24 | $42.3M | $29.5M |
净利润MPBRIGL
| Q4 25 | $19.4M | $268.1M | ||
| Q3 25 | $18.3M | $27.9M | ||
| Q2 25 | $4.8M | $59.6M | ||
| Q1 25 | $13.7M | $11.4M | ||
| Q4 24 | $13.2M | $14.3M | ||
| Q3 24 | $12.3M | $12.4M | ||
| Q2 24 | $11.8M | $-1.0M | ||
| Q1 24 | $12.1M | $-8.2M |
毛利率MPBRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率MPBRIGL
| Q4 25 | 43.6% | 33.2% | ||
| Q3 25 | 39.3% | 40.9% | ||
| Q2 25 | 7.9% | 60.1% | ||
| Q1 25 | 35.2% | 23.9% | ||
| Q4 24 | 34.1% | 28.9% | ||
| Q3 24 | 32.8% | 25.4% | ||
| Q2 24 | 32.4% | 1.2% | ||
| Q1 24 | 34.8% | -23.6% |
净利率MPBRIGL
| Q4 25 | 31.4% | 384.0% | ||
| Q3 25 | 29.6% | 40.2% | ||
| Q2 25 | 8.8% | 58.6% | ||
| Q1 25 | 28.8% | 21.5% | ||
| Q4 24 | 27.9% | 24.9% | ||
| Q3 24 | 27.1% | 22.5% | ||
| Q2 24 | 26.7% | -2.8% | ||
| Q1 24 | 28.7% | -27.9% |
每股收益（稀释后）MPBRIGL
| Q4 25 | $0.83 | $14.11 | ||
| Q3 25 | $0.79 | $1.46 | ||
| Q2 25 | $0.22 | $3.28 | ||
| Q1 25 | $0.71 | $0.63 | ||
| Q4 24 | $0.72 | $0.82 | ||
| Q3 24 | $0.74 | $0.70 | ||
| Q2 24 | $0.71 | $-0.06 | ||
| Q1 24 | $0.73 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $814.1M | $391.5M |
| 总资产 | $6.1B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资MPBRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务MPBRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益MPBRIGL
| Q4 25 | $814.1M | $391.5M | ||
| Q3 25 | $796.3M | $117.6M | ||
| Q2 25 | $775.7M | $81.9M | ||
| Q1 25 | $667.9M | $18.6M | ||
| Q4 24 | $655.0M | $3.3M | ||
| Q3 24 | $573.1M | $-14.6M | ||
| Q2 24 | $559.7M | $-29.9M | ||
| Q1 24 | $551.0M | $-31.7M |
总资产MPBRIGL
| Q4 25 | $6.1B | $513.6M | ||
| Q3 25 | $6.3B | $242.5M | ||
| Q2 25 | $6.4B | $206.7M | ||
| Q1 25 | $5.5B | $176.0M | ||
| Q4 24 | $5.5B | $164.0M | ||
| Q3 24 | $5.5B | $139.4M | ||
| Q2 24 | $5.4B | $128.4M | ||
| Q1 24 | $5.3B | $126.5M |
负债/权益比MPBRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $80.0M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $71.8M | — |
| 自由现金流率自由现金流/营收 | 115.8% | — |
| 资本支出强度资本支出/营收 | 13.3% | — |
| 现金转化率经营现金流/净利润 | 4.12× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $132.1M | — |
8季度趋势，按日历期对齐
经营现金流MPBRIGL
| Q4 25 | $80.0M | $22.0M | ||
| Q3 25 | $26.3M | $24.0M | ||
| Q2 25 | $29.0M | $30.5M | ||
| Q1 25 | $11.5M | $-893.0K | ||
| Q4 24 | $51.4M | $14.5M | ||
| Q3 24 | $16.9M | $21.7M | ||
| Q2 24 | $18.0M | $302.0K | ||
| Q1 24 | $12.4M | $-5.0M |
自由现金流MPBRIGL
| Q4 25 | $71.8M | — | ||
| Q3 25 | $24.3M | — | ||
| Q2 25 | $27.2M | — | ||
| Q1 25 | $8.8M | — | ||
| Q4 24 | $44.5M | — | ||
| Q3 24 | $16.8M | — | ||
| Q2 24 | $17.7M | — | ||
| Q1 24 | $12.1M | — |
自由现金流率MPBRIGL
| Q4 25 | 115.8% | — | ||
| Q3 25 | 39.4% | — | ||
| Q2 25 | 50.1% | — | ||
| Q1 25 | 18.4% | — | ||
| Q4 24 | 93.8% | — | ||
| Q3 24 | 37.1% | — | ||
| Q2 24 | 40.2% | — | ||
| Q1 24 | 28.5% | — |
资本支出强度MPBRIGL
| Q4 25 | 13.3% | — | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | 5.7% | — | ||
| Q4 24 | 14.6% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.8% | — |
现金转化率MPBRIGL
| Q4 25 | 4.12× | 0.08× | ||
| Q3 25 | 1.44× | 0.86× | ||
| Q2 25 | 6.08× | 0.51× | ||
| Q1 25 | 0.84× | -0.08× | ||
| Q4 24 | 3.88× | 1.01× | ||
| Q3 24 | 1.37× | 1.75× | ||
| Q2 24 | 1.53× | — | ||
| Q1 24 | 1.02× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
